相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Glucokinase links Kruppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease
Lars P. Bechmann et al.
HEPATOLOGY (2012)
A small interfering RNA targeting the KLF6 splice variant, KLF6-SV1, as gene therapy for gastric cancer
Hui Chen et al.
GASTRIC CANCER (2011)
Carcinogen-Induced Hepatic Tumors in KLF6+/- Mice Recapitulate Aggressive Human Hepatocellular Carcinoma Associated with p53 Pathway Deregulation
Mirko Tarocchi et al.
HEPATOLOGY (2011)
Chk2 splice variants express a dominant-negative effect on the wild-type Chk2 kinase activity
Elisabet Ognedal Berge et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
Molecular Classification and Novel Targets in Hepatocellular Carcinoma: Recent Advancements
Yujin Hoshida et al.
SEMINARS IN LIVER DISEASE (2010)
KLF6-SV1 Is a Novel Antiapoptotic Protein That Targets the BH3-Only Protein NOXA for Degradation and Whose Inhibition Extends Survival in an Ovarian Cancer Model
Analisa DiFeo et al.
CANCER RESEARCH (2009)
Prostate-specific Klf6 Inactivation Impairs Anterior Prostate Branching Morphogenesis through Increased Activation of the Shh Pathway
Ching Ching Leow et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Targeted reduction of KLF6-SV1 restores chemotherapy sensitivity in resistant lung adenocarcinoma
Jaya Sangodkar et al.
LUNG CANCER (2009)
A functional role for KLF6-SV1 in lung adenocarcinoma prognosis and chemotherapy response
Analisa Difeo et al.
CANCER RESEARCH (2008)
Increased alternative splicing of the KLF6 tumour suppressor gene correlates with prognosis and tumour grade in patients with pancreatic cancer
Mark Hartel et al.
EUROPEAN JOURNAL OF CANCER (2008)
Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma
Steven Yea et al.
GASTROENTEROLOGY (2008)
Kruppel-like transcription factors: A functional family
Richard Pearson et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis
Goutham Narla et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma
G. Narla et al.
ONCOGENE (2007)
Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation
Sigal Kremer-Tal et al.
JOURNAL OF HEPATOLOGY (2007)
E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor
A. DiFeo et al.
ONCOGENE (2006)
Genetic and epigenetic alterations of the KLF6 gene in hepatocellular carcinoma
Jaehwi Song et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
Roles of KLF6 and KLF6-SV1 in ovarian cancer progression and intraperitoneal dissemination
Analisa DiFeo et al.
CLINICAL CANCER RESEARCH (2006)
Methylation status of genes upregulated by demethylating agent 5-aza-2 '-deoxycytidine in hepatocellular carcinoma
Yuichi Hirasawa et al.
ONCOLOGY (2006)
Genetic alterations of the KLF6 gene in gastric cancer
YG Cho et al.
ONCOGENE (2005)
A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk
G Narla et al.
CANCER RESEARCH (2005)
Kruppel-Like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer
HL Reeves et al.
GASTROENTEROLOGY (2004)
Regulation of human p53 activity and cell localization by alternative splicing
A Ghosh et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma
S Kremer-Tal et al.
HEPATOLOGY (2004)
Kruppel-Like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells
G Ito et al.
CANCER RESEARCH (2004)
A new role for the Kruppel-like transcription factor KLF6 as an inhibitor of c-Jun proto-oncoprotein function
DA Slavin et al.
ONCOGENE (2004)
KLF6, a candidate tumor suppressor gene mutated in prostate cancer
G Narla et al.
SCIENCE (2001)